Crossmark

In Vitro Synergistic Activity of Rifampicin Combined with Minimal Effective Antibiotic Concentration (MEAC) of Polymyxin B Against Extensively Drug-Resistant, Carbapenem-, and Polymyxin B-Resistant Klebsiella pneumoniae Clinical Isolates

Crossref DOI link: https://doi.org/10.1007/s00284-024-03897-1

Published Online: 2024-09-22

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abichabki, Nathália

Gaspar, Gilberto Gambero

Zacharias, Luísa Vieira

Pocente, Renata Helena Cândido

Lima, Denissani Aparecida Ferrari Santos

de Freitas, Natália Augusta Barbosa

Brancini, Guilherme Thomaz Pereira

Moreira, Natália Columbaro

Braga, Gilberto Úbida Leite

Bellissimo-Rodrigues, Fernando

Bollela, Valdes Roberto

Darini, Ana Lúcia Costa

Andrade, Leonardo Neves https://orcid.org/0000-0002-9734-5739
Funding

Funding for this research was provided by:

Conselho Nacional de Desenvolvimento Científico e Tecnológico (406192/2023-5, 140875/2024-7)

Instituto Nacional de Pesquisas em Resistência a Antimicrobianos (INCT – MCTI/CNPq/CAPES/FAPs nº 16/2014, INCT – MCTI/CNPq/CAPES/FAPs nº 16/2014)

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88887.670254/2022-0, 8887.716776/2022-00)
License Information

Text and Data Mining valid from 2024-09-22

Version of Record valid from 2024-09-22
More Information

Article History

Received: 5 August 2024

Accepted: 11 September 2024

First Online: 22 September 2024

Declarations

:

: None to declare.

: This study was approved by the Ethics Committee of the School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (CAAE: 48834921.9.0000.5403—Protocol CEP/FCFRP nº580).

Document is current

Any future updates will be listed below